Head & Neck Cancer

The term head and neck cancer includes tumors arising in the mouth, throat, larynx, sinuses, lymph nodes, salivary glands, and thyroid gland. There are 50,000 new cases annually in the United States according to the National Cancer Institute, and it is the sixth most common type of cancer worldwide. Tobacco and heavy alcohol use are traditional risk factors. Infection with human papillomavirus (HPV) causes many types of head and neck cancer in non-tobacco users, however, and has become a significant problem throughout the developed world.  

Duke is a high-volume referral center for treatment of head and neck cancers. Physicians within this disease group are internationally recognized research and clinical experts who make these diseases their primary focus. Duke Cancer Institute's Head and Neck Cancer disease group has developed treatment innovations that now constitute the standard of care, such as a combination of intensive radiation therapy and simultaneous chemotherapy for advanced-stage head and neck cancer, operations that result in better function and less disfigurement, and the utilization of PET scanning before and after treatment to guide decision making.

Our team of specialists in head and neck oncologic surgery, plastic and reconstructive surgery, radiation oncology, medical oncology, radiology and pathology ensure that each patient receives state-of-the-art treatment—supported by the most advanced technology available anywhere. Robust speech pathology, audiology, and patient support services also play an active role in helping patients maintain quality of life throughout treatment and recovery.

We've created a new model for integrated care for the treatment of head and neck cancer embraced by cancer centers across the world.